Query Result Set
Skip Navigation Links
   ActiveUsers:481Hits:19920128Skip Navigation Links
Show My Basket
Contact Us
IDSA Web Site
Ask Us
Today's News
HelpExpand Help
Advanced search

  Hide Options
Sort Order Items / Page
PATENT REGIME (3) answer(s).
 
SrlItem
1
ID:   157667


Efficiency and its determinants: panel data evidence from the Indian pharmaceutical industry / Mahajan, Varun; Nauriyal, D K; Singh, S P   Journal Article
Singh, S P Journal Article
0 Rating(s) & 0 Review(s)
Summary/Abstract The study determines the efficiency of Indian pharmaceutical firms and its determinants in the pre- and post-product patent regime. Overall inefficiency in the industry is higher due to the inefficient conversion of inputs into output rather than through scale inefficiency. The study finds that the Product Patent Act has a negative impact on efficiency. Ownership, capital imports intensity and size variables are positively related with efficiency scores whereas age, time dummy and size square variables are inversely related. The study supports the finding that with an increase in mergers and acquisitions, a movement towards diversifying operations, the use of advanced imported foreign technology, investment in fixed assets and judicious allocation of resources for marketing activities could improve firm performance. For future policy implications, the small firms may either merge into bigger entities or manufacture pharmaceutical products for other companies, so as to raise operational scale and improve capacity utilisation.
        Export Export
2
ID:   110293


FDI flows into the Indian pharmaceutical industry: an analysis of trends and constraints / Tripathy, Ishita G; Yadav, Surendra S; Sharma, Seema   Journal Article
Tripathy, Ishita G Journal Article
0 Rating(s) & 0 Review(s)
Publication 2011.
Summary/Abstract India's economic reforms since 1990s and World Trade Organisation's Agreement on Trade-Related Aspects of Intellectual Property Rights have caused significant changes in the operational environment of the Indian pharmaceutical industry (IPI). In this backdrop, this study examines the Foreign Direct Investment (FDI) flows into the firms of IPI. It finds that the amount of FDI, the number of FDI recipient firms and the number of source countries of FDI are larger during the product patent regime as compared to the process patent regime. The factor analysis of primary data presents the perception of 64 sample firms of IPI as regards the main constraints of FDI inflows in the product patent regime.
        Export Export
3
ID:   096422


Patent regime and nanotechnology: issues and challenges / Barpujari, Indrani   Journal Article
Barpujari, Indrani Journal Article
0 Rating(s) & 0 Review(s)
Publication 2010.
        Export Export